FSPHX
Price
$30.12
Change
-$0.01 (-0.03%)
Updated
Nov 18 closing price
Net Assets
6.22B
PHSZX
Price
$51.05
Change
+$0.08 (+0.16%)
Updated
Nov 19 closing price
Net Assets
1.5B
Interact to see
Advertisement

FSPHX vs PHSZX

Header iconFSPHX vs PHSZX Comparison
Open Charts FSPHX vs PHSZXBanner chart's image
Fidelity Select Health Care
Price$30.12
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets6.22B
PGIM Jennison Health Sciences Z
Price$51.05
Change+$0.08 (+0.16%)
VolumeN/A
Net Assets1.5B
FSPHX vs PHSZX Comparison Chart in %
View a ticker or compare two or three
VS
FSPHX vs. PHSZX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Hold and PHSZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. PHSZX (1.5B). PHSZX pays higher dividends than FSPHX: PHSZX (0.73) vs FSPHX (0.02). FSPHX was incepted earlier than PHSZX: FSPHX (44 years) vs PHSZX (26 years). PHSZX (0.86) is less costly to investors than FSPHX (0.63). PHSZX is a more actively managed with annual turnover of: 79.00 vs. FSPHX (40.00). FSPHX (0) and PHSZX (0) have matching initial minimum investment requirements. PHSZX annual gain was more profitable for investors over the last year : 4.84 vs. FSPHX (0.02). FSPHX return over 5 years is better than : -8.84 vs. PHSZX (-18.35).
FSPHXPHSZXFSPHX / PHSZX
Total Expense Ratio0.630.8673%
Annual Report Gross Expense Ratio0.630.8673%
Fund Existence44 years26 years-
Gain YTD10.53217.11962%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.22B1.5B415%
Annual Yield % from dividends0.020.732%
Returns for 1 year0.024.840%
Returns for 3 years10.4727.5038%
Returns for 5 years-8.84-18.3548%
Returns for 10 years39.34-2.82-1,397%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5